Medicale Corp. Stock

Equities

MCLE

US58464K1025

Pharmaceuticals

Market Closed - OTC Markets 15:23:37 2024-06-28 EDT 5-day change 1st Jan Change
0.27 USD +10.20% Intraday chart for Medicale Corp. +438.92% +80.00%
Sales 2022 - Sales 2023 - Capitalization 2.6M 3.56M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 17.77K 24.3K Net Debt 2023 20.32K 27.78K EV / Sales 2023 -
P/E ratio 2022
-255 x
P/E ratio 2023
-70.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 45.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day+10.20%
1 week+438.92%
1 month+157.14%
3 months+107.69%
6 months+80.00%
Current year+80.00%
More quotes
1 week
0.10
Extreme 0.1
0.35
1 month
0.05
Extreme 0.05
0.35
Current year
0.04
Extreme 0.035
0.35
1 year
0.04
Extreme 0.035
7.27
3 years
0.04
Extreme 0.035
7.27
5 years
0.04
Extreme 0.035
7.27
10 years
0.04
Extreme 0.035
7.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 22-12-27
Members of the board TitleAgeSince
Chief Executive Officer 62 22-12-27
More insiders
Date Price Change Volume
24-06-28 0.27 +10.20% 15,632
24-06-27 0.245 +25.61% 28,709
24-06-26 0.195 +30.03% 33,623
24-06-25 0.15 +165.49% 75,332

Delayed Quote OTC Markets, June 28, 2024 at 03:23 pm

More quotes
Medicale Corp. intends to offer consulting services and distribution of the dietary supplements. The dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. The supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, to enhance the quantity of their consumption. The Company has not commenced any operations.
More about the company